Glimepiride Treatment and IGF-I in Adolescents With Type 1 Diabetes: A prospective, randomized, double-blind, placebo-controlled study

S. A. Wudy; J. Hogel; B. Dollinger; P. Mullis; E. Heinze

doi:10.2337/diacare.26.4.1312

Glimepiride Treatment and IGF-I in Adolescents With Type 1 Diabetes: A prospective, randomized, double-blind, placebo-controlled study

Diabetes Care ◽

10.2337/diacare.26.4.1312 ◽

2003 ◽

Vol 26 (4) ◽

pp. 1312-1313 ◽

Cited By ~ 2

Author(s):

S. A. Wudy ◽

J. Hogel ◽

B. Dollinger ◽

P. Mullis ◽

E. Heinze

Keyword(s):

Type 1 Diabetes ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Igf I

Download Full-text

Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double-blind placebo-controlled study

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.176 ◽

2001 ◽

Vol 17 (2) ◽

pp. 131-136 ◽

Cited By ~ 27

Author(s):

J. Ludvigsson ◽

U. Samuelsson ◽

C. Johansson ◽

L. Stenhammar

Keyword(s):

Type 1 Diabetes ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double-blind Placebo-controlled Study of the Effects of Bezafibrate on Blood Lipids, Lipoproteins, and Fibrinogen in Hyperlipidaemic Type 1 Diabetes Mellitus

Diabetic Medicine ◽

10.1111/j.1464-5491.1990.tb01479.x ◽

1990 ◽

Vol 7 (8) ◽

pp. 736-743 ◽

Cited By ~ 15

Author(s):

P.H. Winocour ◽

P.N. Durrington ◽

D. Bhatnagar ◽

M. Ishola ◽

S. Arrol ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Blood Lipids ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

BMJ Open ◽

10.1136/bmjopen-2015-007791 ◽

2015 ◽

Vol 5 (4) ◽

pp. e007791-e007791 ◽

Cited By ~ 9

Author(s):

T. F. Dejgaard ◽

F. K. Knop ◽

L. Tarnow ◽

C. S. Frandsen ◽

T. S. Hansen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Therapy ◽

Receptor Agonist ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100895 ◽

2021 ◽

pp. 100895

Author(s):

Jens Christian Laursen ◽

Niels Søndergaard-Heinrich ◽

Joana Mendes Lopes de Melo ◽

Bryan Haddock ◽

Ida Kirstine Bull Rasmussen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Crossover Trial ◽

Acute Effects ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial

Diabetologia ◽

10.1007/s00125-021-05547-8 ◽

2021 ◽

Author(s):

Sebastian M. N. Heimbürger ◽

Bjørn Hoe ◽

Chris N. Nielsen ◽

Natasha C. Bergmann ◽

Bolette Hartmann ◽

...

Keyword(s):

Type 1 Diabetes ◽

Crossover Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.740412722.793587361 ◽

2021 ◽

Author(s):

Emily Sims

Keyword(s):

Type 1 Diabetes ◽

Imatinib Therapy ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Recent Onset ◽

Onset Type ◽

Phase 2 Trial

Download Full-text

Effects of sitagliptin on counter‐regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double‐blind placebo‐controlled crossover study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12453 ◽

2015 ◽

Vol 17 (6) ◽

pp. 546-553 ◽

Cited By ~ 13

Author(s):

J. E. Schopman ◽

J. B. L. Hoekstra ◽

B. M. Frier ◽

M. T. Ackermans ◽

J. J. J. de Sonnaville ◽

...

Keyword(s):

Type 1 Diabetes ◽

Crossover Study ◽

Incretin Hormones ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double‐blind, placebo‐controlled trial

United European Gastroenterology Journal ◽

10.1177/2050640620925968 ◽

2020 ◽

Vol 8 (6) ◽

pp. 695-704

Author(s):

Anne‐Marie Langmach Wegeberg ◽

Christian Stevns Hansen ◽

Adam D Farmer ◽

Jesper Scott Karmisholt ◽

Asbjorn M Drewes ◽

...

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Colonic Transit ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Review for "Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial"

10.1111/dom.14078/v2/review3 ◽

2020 ◽

Keyword(s):

Cardiovascular Disease ◽

Type 1 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Short Acting

Download Full-text

Review for "Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial"

10.1111/dom.14078/v1/review3 ◽

2020 ◽

Keyword(s):

Cardiovascular Disease ◽

Type 1 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Short Acting

Download Full-text